BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sipeki N, Kovats PJ, Deutschmann C, Schierack P, Roggenbuck D, Papp M. Location-based prediction model for Crohn’s disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies. World J Gastroenterol 2023; 29(42): 5728-5750 [PMID: 38075846 DOI: 10.3748/wjg.v29.i42.5728]
URL: https://www.wjgnet.com/1007-9327/full/v29/i42/5728.htm
Number Citing Articles
1
Francisca A. Castillo, Bianca C. Kern, Eduardo J. Villablanca. B cells in inflammatory bowel diseaseImmunology Letters 2026; 277: 107071 doi: 10.1016/j.imlet.2025.107071
2
Yi Deng, Dan Wang, Chao Wang, Kaiyun Guo, Ming Lei, Yanzhao Huang, Langui Tang, Ya Ding, Yan Gao. Serum CHI3L1 levels correlate with disease activity in rheumatoid arthritis and reveal potential molecular mechanismsFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1729989
3
Yuan Gao, Hong Chen, Ruolan Wu, ZuJun Zhou. AI-driven multi-omics profiling of sepsis immunity in the digestive systemFrontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1590526
4
Dong Liu, Xin Hu, Xiao Ding, Ming Li, Lei Ding. Inflammatory Effects and Regulatory Mechanisms of Chitinase-3-like-1 in Multiple Human Body Systems: A Comprehensive ReviewInternational Journal of Molecular Sciences 2024; 25(24): 13437 doi: 10.3390/ijms252413437
5
D. A. Kuznetsova, S. V. Lapin, O. B. Shchukina, I. V. Gubonina, А. А. Kamanin, D. A. Davydov, V. L. Emanuel. Diagnostic and prognostic significance of pancreatic autoantibodies and intestinal goblet cell antibodies in inflammatory bowel diseasesMedical alphabet 2025; (5): 26 doi: 10.33667/2078-5631-2025-5-26-33
6
Xiaoshan Li, Mengyun Cao, Junling Zhang. CHI3L1: From Inflammation to Cancer — A Molecular Hub in Multisystem Diseases and Novel Target for Precision MedicineFrontiers in Preventive Medicine 2025; 1(2): 69 doi: 10.64904/fpm25008